Evidence map›Paper›PMID 10818136›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2000

Intracellular modulation of NMDA receptor function by antipsychotic drugs.

J C Leveque, W Macías, A Rajadhyaksha, R R Carlson, A Barczak, S Kang, X M Li, J T Coyle, R L Huganir, S Heckers and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 149 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Clozapine As Transformative Treatment In Bipolar Patients.Neuropsychiatric disease and treatment · 2019
    Article
  10. Article
  11. Multi-Target Approach for Drug Discovery against Schizophrenia.International journal of molecular sciences · 2018
    Review
  12. Current Concepts and Treatments of Schizophrenia.Molecules (Basel, Switzerland) · 2018
    Review
  13. Article
  14. Existing and novel biological therapeutics in suicide prevention.American journal of preventive medicine · 2014
    Article
  15. Article
  16. Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Article
  17. Article
  18. Article
  19. The relationship between duration of initial alcohol exposure and persistence of molecular tolerance is markedly nonlinear.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

J C LevequeMolecular and Developmental Neuroscience Laboratory and Department of Psychiatry, Massachusetts General Hospital East, Charlestown, Massachusetts 02129, USA.
W Macías
A Rajadhyaksha
R R Carlson
A Barczak
S Kang
X M Li
J T Coyle
R L Huganir
S Heckers
C Konradi
Massachusetts General Hospital · USHarvard University · USMcLean Hospital · USHoward Hughes Medical Institute · USRoyal University Hospital · CA

Funding

PSYCHOSTIMULANT REGULATION OF NEURAL GENE EXPRESSIONR01DA007134 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI KONRADI, CHRISTINE L · 1991 to 2003
$1.1M
NIDA NIH HHS DA07134NIDA NIH HHS R01 DA007134
6 · The paper itself

Abstract

The present study deals with the functional interaction of antipsychotic drugs and NMDA receptors. We show that both the conventional antipsychotic drug haloperidol and the atypical antipsychotic drug clozapine mediate gene expression via intracellular regulation of NMDA receptors, albeit to different extents. Data obtained in primary striatal culture demonstrate that the intraneuronal signal transduction pathway activated by haloperidol, the cAMP pathway, leads to phosphorylation of the NR1 subtype of the NMDA receptor at (897)Ser. Haloperidol treatment is likewise shown to increase (897)Ser-NR1 phosphorylation in rats in vivo. Mutation of (896)Ser and (897)Ser to alanine, which prevents phosphorylation at both sites, inhibits cAMP-mediated gene expression. We conclude that antipsychotic drugs have the ability to modulate NMDA receptor function by an intraneuronal signal transduction mechanism. This facilitation of NMDA activity is necessary for antipsychotic drug-mediated gene expression and may contribute to the therapeutic benefits as well as side effects of antipsychotic drug treatment.

Indexed as

AnimalsAntipsychotic AgentsBlotting, NorthernCells, CulturedClozapineCycloserineDizocilpine MaleateExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsGene Expression RegulationGenes, fosHaloperidolMaleNeostriatumNeuronsPhosphorylationAntipsychotic AgentsClozapineCycloserineDizocilpine MaleateExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsHaloperidolReceptors, N-Methyl-D-Aspartate

Identifiers

PMID10818136
PMCPMC4203343
OpenAlexW1499413566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.